The cell culture media market size is estimated to be USD 6,350.7 million in 2022 and is expected to witness a CAGR of 18.58 during the forecast period 2023-2033. The increasing attention on individualized medicine, escalating pharmaceutical company R&D expenditures, innovative cell culture techniques for cell-based vaccinations, expansion of stem cell studies, rising need for monoclonal antibodies, and release of fresh cell culture media items by industry participants are factors contributing to the market growth. However, the ethical issues with cell biology research and costly cell biology research materials is expected to hinder the growth.

Segmentation

By Application

On the basis of Application, the market is segregated into monoclonal antibodies, vaccines production, biopharmaceutical production, diagnostics, drug screening & development, tissue engineering & regenerative medicine, cell and gene therapy, and other therapeutic proteins, other applications, and other regenerative medicine & tissue engineering applications. In 2022, the biopharmaceutical production segment held the highest market share owing to the rapidly rising biopharmaceutical industry’s need for more repeatable and better-defined media to match the escalating production levels while lowering the risk of contamination in the downstream procedures.

By Type

Based on type, the market is categorized into BHK media, CHO media, serum-free media, HEK 293 media, CAR T-cell media, serum-free stem cell media, insect cell media, vero cell media, chemically defined media, specialty media, stem cell culture media, classical media & salts, other serum-free media, and other cell culture media. In 2022, the serum-free media segment held the highest market share owing to a fast expanding field in gene and cell therapy, greater production, more effective management of physiological sensitivity, and increased performance consistency.

By End User

On the basis of end-user, the market is divided into research & academic institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users. In 2022, the pharmaceutical & biotechnology companies segment held the highest market share owing to the expanding the number of clinical studies and extension of present biopharmaceutical production capabilities.

Regional Markets

In 2022, North America region accounted for the highest revenue in the cell culture media market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing prevalence of illnesses like cancer combined with funding and investments in cell-based research, expansion of biotechnology and pharmaceutical industries, and increasing approvals for vaccines based on cell culture. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to strategic initiatives taken by major players to increase their influence in the Asia Pacific nations, and rise in public awareness connected with the employment of cell culture techniques.

Competitor Insights

Some of the key players operating in the cell culture media market are Cell Biologics, Inc. (US), Corning Incorporated (US), CYTIVA (US), Danaher Corporation (US), FUJIFILM Irvine Scientific, Inc. (US), InvivoGen (US), Lonza Group AG (Switzerland), Merck KGaA (Germany), PromoCell GmbH (Germany), Sartorius AG (Germany), STEMCELL Technologies Inc. (Canada), and Thermo Fisher Scientific Inc. (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including application, type, and end user from 2022 to 2033.

Report Scope:

Segmentation: Cell Culture Media Market Report 2022 – 2033

Application (Revenue, USD Million), 2022 – 2033

• Monoclonal antibodies
• Vaccines production
• Biopharmaceutical Production
• Diagnostics
• Drug Screening & Development
• Tissue Engineering & Regenerative Medicine
• Cell and gene therapy
• Other therapeutic proteins
• Other Applications
• Other regenerative medicine & tissue engineering applications

Type (Revenue, USD Million), 2022 – 2033

• BHK Media
• CHO Media
• Serum-free Media
• HEK 293 Media
• CAR T-cell Media
• Serum-free Stem Cell Media
• Insect Cell Media
• VERO Cell Media
• Chemically defined Media
• Specialty Media
• Stem Cell Culture Media
• Classical Media & Salts
• Other Serum-free Media
• Other Cell Culture Media

End User (Revenue, USD Million), 2022 – 2033

• Research & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Other End Users

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA